Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000578612 | SCV000681094 | pathogenic | not provided | 2025-01-13 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Identified in unrelated individuals with kidney disease and in the published literature (PMID: 39136524); This variant is associated with the following publications: (PMID: 39136524) |
Blueprint Genetics | RCV001075043 | SCV001240654 | likely pathogenic | Retinal dystrophy | 2018-05-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001230423 | SCV001402901 | pathogenic | Saldino-Mainzer syndrome | 2024-10-29 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Cys1313*) in the IFT140 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IFT140 are known to be pathogenic (PMID: 22503633, 23418020, 24009529, 26216056). This variant is present in population databases (no rsID available, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with IFT140-related conditions. ClinVar contains an entry for this variant (Variation ID: 489108). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV002506390 | SCV002811535 | likely pathogenic | Saldino-Mainzer syndrome; Retinitis pigmentosa 80 | 2024-06-17 | criteria provided, single submitter | clinical testing |